Evidence map›Paper›PMID 39776186›Full record

ArticleGenetics2025

The Candida Genome Database: annotation and visualization updates.

Jodi Lew-Smith, Jonathan Binkley, Gavin Sherlock

Abstract read
In one paragraph

Article in Genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Two Ume6 target gene classes in the biofilm regulatory network ofbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Proteome Remodelling inJournal of fungi (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Micafungin exposure drives multidrug resistance inbioRxiv : the preprint server for biology · 2026
    Article
  10. JAC-antimicrobial resistance · 2026
    Article
  11. Article
  12. Defining thebioRxiv : the preprint server for biology · 2026
    Article
  13. Article
  14. Review
  15. Impact ofmSphere · 2026
    Article
  16. Profound cell wall remodeling inMicrobiology spectrum · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jodi Lew-SmithDepartment of Genetics, Stanford University, Stanford CA 94305-5120, USA.
Jonathan BinkleyDepartment of Genetics, Stanford University, Stanford CA 94305-5120, USA.
Gavin SherlockDepartment of Genetics, Stanford University, Stanford CA 94305-5120, USA.ORCID 0000-0002-1692-4983

Funding

Genomic Database for Candida AlbicansR01DE015873 · NIDCR · STANFORD UNIVERSITY · PI Gavin J Sherlock · 2004 to 2026
$11.7M
NIDCR/NIHNIDCR NIH HHS R01 DE015873
6 · The paper itself

Abstract

The Candida Genome Database (CGD; www.candidagenome.org) is unique in being both a model organism database and a fungal pathogen database. As a fungal pathogen database, CGD hosts locus pages for 5 species of the best-studied pathogenic fungi in the Candida group. As a model organism database, the species Candida albicans serves as a model both for other Candida spp. and for non-Candida fungi that form biofilms and undergo routine morphogenic switching from the planktonic form to the filamentous form, which is not done by other model yeasts. As pathogenic Candida species have become increasingly drug resistant, the high lethality of invasive candidiasis in immunocompromised people is increasingly alarming. There is a pressing need for additional research into basic Candida biology, epidemiology and phylogeny, and potential new antifungals. CGD serves the needs of this diverse research community by curating the entire gene-based Candida experimental literature as it is published, extracting, organizing, and standardizing gene annotations. Gene pages were added for the species Candida auris, recent outbreaks of which have been labeled an "urgent" threat. Most recently, we have begun linking clinical data on disease to relevant Literature Topics to improve searchability for clinical researchers. Because CGD curates for multiple species and most research focuses on aspects related to pathogenicity, we focus our curation efforts on assigning Literature Topic tags, collecting detailed mutant phenotype data, and assigning controlled Gene Ontology terms with accompanying evidence codes. Our Summary pages for each feature include the primary name and all aliases for that locus, a description of the gene and/or gene product, detailed ortholog information with links, a JBrowse window with a visual view of the gene on its chromosome, summarized phenotype, Gene Ontology, and sequence information, references cited on the summary page itself, and any locus notes. The database serves as a community hub, where we link to various types of reference material of relevance to Candida researchers, including colleague information, news, and notice of upcoming meetings. We routinely survey the community to learn how the field is evolving and how needs may have changed. For example, we asked our users which species we should next add to CGD, and the clear answer was Candida tropicalis. A key future challenge is management of the flood of high-throughput expression data to make it as useful as possible to as many researchers as possible. The central challenge for any community database is to turn data into knowledge, which the community can access, use, and build upon.

Indexed as

CandidaDatabases, GeneticGenome, FungalMolecular Sequence AnnotationCandidiasisHumanscandidadatabaseyeast

Identifiers

PMID39776186
PMCPMC12168076

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.